Journal of Neuro-Oncology

, Volume 43, Issue 3, pp 199-201

First online:

Epidemiology of Primary CNS Lymphoma

  • Martin SchabetAffiliated withDepartment of Neurology, University of Tuebingen

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


In the beginning of the nineties the National Cancer Institute Surveillance, Epidemiology, and End Results Program calculated the incidence of primary central nervous system non-Hodgkin's lymphoma (PCNSL) as 1:100 000. The incidence of PCNSL has been increasing since the seventies in immunocompetent patients. The main increase, however, is taking place since the mid-eighties and is due to the increase of immunodeficieny and immunosuppression. The risk is 2–6% in AIDS patients according to clinical data and will probably further increase with the length of survival in these patients. Transplant patients carry a risk of 1–5% to develop a PCNSL. The risk is 1–2% for renal, and 2–7% for cardiac, lung or liver transplant recipients. Patients with congenital immune deficiency have a risk of 4%. PCNSL may also present as a secondary malignancy.

epidemiology non-Hodgkin's lymphoma primary CNS lymphoma